Mitsuyoshi Tei1, Masaki Wakasugi2, Hiroki Akamatsu2. 1. Department of Surgery, Osaka Police Hospital, 10-31, Kitayama-cho, Tennoji-ku, Osaka City, Osaka 543-0035, Japan. Electronic address: mtei@live.jp. 2. Department of Surgery, Osaka Police Hospital, 10-31, Kitayama-cho, Tennoji-ku, Osaka City, Osaka 543-0035, Japan.
Abstract
BACKGROUND: Single-port surgery is a recent advancement in minimally invasive techniques for colon disease. However, single-port laparoscopic rectal resection (SPLR) is rare. The aim of this study was to compare the short-term results of SPLR with those of multi-port laparoscopic rectal resection (MPLR) for rectal cancer. METHODS: Patients who underwent SPLR (n = 50) or MPLR (n = 50) for rectal cancer from July 2010 to March 2014 were analyzed. Patients with tumor diameter less than 40 mm and body mass index less than 30 kg/m(2) were matched for age, sex, tumor location, and preoperative evaluation. Operative parameters and outcomes were compared between groups. Patients with lower rectal cancer were excluded. RESULTS: SPLR was successful in 98.0% of cases. Operative procedure, operative time, blood loss, field of lymph node dissection, and rate of postoperative complications did not differ significantly. Length of hospital stay was shorter with SPLR than with MPLR (8 vs 10 days, respectively; P = .018). Oncological outcomes did not differ significantly between the 2 groups. CONCLUSION: SPLR is safe and feasible in selected patients with rectal cancer.
BACKGROUND: Single-port surgery is a recent advancement in minimally invasive techniques for colon disease. However, single-port laparoscopic rectal resection (SPLR) is rare. The aim of this study was to compare the short-term results of SPLR with those of multi-port laparoscopic rectal resection (MPLR) for rectal cancer. METHODS:Patients who underwent SPLR (n = 50) or MPLR (n = 50) for rectal cancer from July 2010 to March 2014 were analyzed. Patients with tumor diameter less than 40 mm and body mass index less than 30 kg/m(2) were matched for age, sex, tumor location, and preoperative evaluation. Operative parameters and outcomes were compared between groups. Patients with lower rectal cancer were excluded. RESULTS: SPLR was successful in 98.0% of cases. Operative procedure, operative time, blood loss, field of lymph node dissection, and rate of postoperative complications did not differ significantly. Length of hospital stay was shorter with SPLR than with MPLR (8 vs 10 days, respectively; P = .018). Oncological outcomes did not differ significantly between the 2 groups. CONCLUSION: SPLR is safe and feasible in selected patients with rectal cancer.
Authors: Salvador Morales-Conde; Andrea Peeters; Yannick M Meyer; Stavros A Antoniou; Isaías Alarcón Del Agua; Alberto Arezzo; Simone Arolfo; Amir Ben Yehuda; Luigi Boni; Elisa Cassinotti; Giovanni Dapri; Tao Yang; Sofie Fransen; Antonello Forgione; Shahab Hajibandeh; Shahin Hajibandeh; Michele Mazzola; Marco Migliore; Christof Mittermair; Doris Mittermair; Antonio Morandeira-Rivas; Carlos Moreno-Sanz; Andrea Morlacchi; Eran Nizri; Myrthe Nuijts; Jonas Raakow; Francisco M Sánchez-Margallo; Juan A Sánchez-Margallo; Amir Szold; Helmut Weiss; Michael Weiss; Ricardo Zorron; Nicole D Bouvy Journal: Surg Endosc Date: 2019-02-15 Impact factor: 4.584